LISI (EPA:FII) - The LISI Group confirms finalization of the acquisition of 100% of RTI REMMELE Medical, Inc.
Transparency directive : regulatory news
02/05/2016 08:55
Click here to download pdf version
Belfort, May 2, 2016
The LISI Group confirms finalization of the acquisition of 100% of RTI REMMELE
Medical, Inc.
The LISI Group (Euronext Paris - ISIN code: FR 0000050353) today announced the
finalization of acquisition of 100% of RTI REMMELE Medical, Inc.
This announcement concludes the process initially disclosed in the press release
issued on April 11, 2016; it reaffirms the strategy of LISI MEDICAL which aims
to strengthen its globally recognized position as a specialist in the production
of prosthetics and medical instruments.
This transaction was carried out through Hi Shear Corporation, 100% subsidiary
of LISI AEROSPACE.
Effective April 30, 2016 the transaction leads to the LISI Group consolidating
LISI MEDICAL Remmele as of May 1, 2016 and represents a major step in the
development of the Group.
Contact
Emmanuel VIELLARD
Telephone: 03 84 57 00 77
Email: emmanuel.viellard@lisi-group.com
Website: www.lisi-group.com
LISI is listed on Euronext, compartment A and is listed on CAC(r) AERO & DEF.,
CAC(r) All Shares, CAC(r) - All Tradable, CAC(r) Industrials, CAC(r) Mid &
Small, and CAC(r) Small, under the ISIN code: FR 0000050353.
LISI is a world leader in fasteners and assembly components for the aerospace,
automobile and medical implants sectors.
Reuters Code: GFII.PA
Bloomberg Code: FII FP